The relationship of the renal vascular activity of angiotensin II to the autonomic nervous system.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001775:Blood Circulation; D001949:Bretylium Compounds / Q000494:pharmacology*; D002818:Cordotomy; D003714:Denervation; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology*; D006145:Guanethidine / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D006830:Hydralazine / Q000494:pharmacology*; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects*; D009539:Nicotinic Acids / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D012039:Regional Blood Flow; D013564:Sympathetic Nervous System / Q000502:physiology*; D014439:Tyramine / Q000494:pharmacology*
D001949:Bretylium Compounds; D006584:Hexamethonium Compounds; D009539:Nicotinic Acids; D000804:Angiotensin II; D006830:Hydralazine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine; D006145:Guanethidine